Find Iomeprol manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Canada

Canada

0

Australia

Australia

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 78649-41-9, Iomeprolum, Iomeron, Imeron, Iomeron 300, N,n'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-(n-methylglycolamido)isophthalamide
Molecular Formula
C17H22I3N3O8
Molecular Weight
777.1  g/mol
InChI Key
NJKDOADNQSYQEV-UHFFFAOYSA-N
FDA UNII
17E17JBP8L

Iomeprol
Iomeprol has been investigated for the diagnostic of Coronary Artery Disease.
1 2D Structure

Iomeprol

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1-N,3-N-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)-methylamino]-2,4,6-triiodobenzene-1,3-dicarboxamide
2.1.2 InChI
InChI=1S/C17H22I3N3O8/c1-23(9(29)6-26)15-13(19)10(16(30)21-2-7(27)4-24)12(18)11(14(15)20)17(31)22-3-8(28)5-25/h7-8,24-28H,2-6H2,1H3,(H,21,30)(H,22,31)
2.1.3 InChI Key
NJKDOADNQSYQEV-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CN(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)CO
2.2 Other Identifiers
2.2.1 UNII
17E17JBP8L
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Imeron

2. Iomeprol 350

3. Iomeprol 400

4. Iomeron

2.3.2 Depositor-Supplied Synonyms

1. 78649-41-9

2. Iomeprolum

3. Iomeron

4. Imeron

5. Iomeron 300

6. N,n'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-(n-methylglycolamido)isophthalamide

7. N1,n3-bis(2,3-dihydroxypropyl)-5-(2-hydroxy-n-methylacetamido)-2,4,6-triiodoisophthalamide

8. E-7337

9. 1-n,3-n-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)-methylamino]-2,4,6-triiodobenzene-1,3-dicarboxamide

10. 17e17jbp8l

11. 1185146-41-1

12. Chebi:31710

13. N,n'-bis(2,3-dihydroxypropyl)-5-[glycoloyl(methyl)amino]-2,4,6-triiodoisophthalamide

14. Ncgc00183283-01

15. Iomeprolo

16. E7337

17. 1,3-benzenedicarboxamide, N,n'-bis(2,3-dihydroxypropyl)-5-((hydroxyacetyl)methylamino)-2,4,6-triiodo-

18. Iomeprolum [inn-latin]

19. Unii-17e17jbp8l

20. Iomeprol [usan:inn:ban:jan]

21. Iomeprol [usan]

22. Iomeprol [inn]

23. Iomeprol [jan]

24. Iomeprol [mi]

25. Iomeron 300 (tn)

26. Iomeprol [mart.]

27. Iomeprol [who-dd]

28. Dsstox_cid_28987

29. Dsstox_rid_83252

30. Dsstox_gsid_49061

31. Schembl26981

32. Iomeprol (jan/usan/inn)

33. Chembl2107214

34. Dtxsid1049061

35. Bcp34386

36. Tox21_113611

37. Akos030255901

38. Db11705

39. Ac-30722

40. Cas-78649-41-9

41. Db-056324

42. Ft-0627277

43. Ft-0670399

44. Methylacetamido)-2,4,6-triiodoisophthalamide

45. D01719

46. Iomeprol 100 Microg/ml In Acetonitrile/methanol

47. Iomeprol 100 Microg/ml In Acetonitrile:methanol

48. A839467

49. B-16880

50. N1,n3-bis(2,3-dihydroxypropyl)-5-(2-hydroxy-n-

51. Q6062808

52. 1,3-benzenedicarboxamide, N1,n3-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)methylamino]-2,4,6-triiodo-

2.4 Create Date
2005-03-25
3 Chemical and Physical Properties
Molecular Weight 777.1 g/mol
Molecular Formula C17H22I3N3O8
XLogP3-2.3
Hydrogen Bond Donor Count7
Hydrogen Bond Acceptor Count8
Rotatable Bond Count10
Exact Mass776.8541 g/mol
Monoisotopic Mass776.8541 g/mol
Topological Polar Surface Area180 Ų
Heavy Atom Count31
Formal Charge0
Complexity591
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count2
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Contrast Media

Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)


4.2 ATC Code

V08AB10

S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355


V - Various

V08 - Contrast media

V08A - X-ray contrast media, iodinated

V08AB - Watersoluble, nephrotropic, low osmolar x-ray contrast media

V08AB10 - Iomeprol


Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty